Capital World Investors 13D/13G Filings for CRISPR Therapeutics AG (CRSP)

Capital World Investors 13D and 13G filings for CRISPR Therapeutics AG:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-14
1:55 pm
Purchase
2026-03-3113GCRISPR THERAPEUTICS AG NAMEN A
CRSP
Capital World Investors4,929,428
5.100%
4,929,428increase
(New Position)
Filing